Cargando…

The role of opioid receptors in modulating Alzheimer’s Disease

Alzheimer’s disease (AD) is a complex neurological disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles. Long term investigation of AD pathogenesis suggests that β-site amyloid precursor protein [APP] cleaving enzyme 1 (BACE1) and γ-secretase enzymes promote the amyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanguturi, Parthasaradhireddy, Streicher, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014470/ https://www.ncbi.nlm.nih.gov/pubmed/36937877 http://dx.doi.org/10.3389/fphar.2023.1056402

Ejemplares similares

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2021)

Correction: Tanguturi et al. Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. Molecules 2021, 26, 6693
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2022)

Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP(1–23)
por: Apostol, Christopher R., et al.
Publicado: (2021)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
por: Ugur, Muzeyyen, et al.
Publicado: (2018)

Exploring the Role of P2X Receptors in Alzheimer’s Disease
por: Godoy, Pamela Andrea, et al.
Publicado: (2019)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

Cannabinoid CB(2) Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
por: Ruiz de Martín Esteban, Samuel, et al.
Publicado: (2022)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022)

Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
por: Leconte, Claire, et al.
Publicado: (2022)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Does the kappa opioid receptor system contribute to pain aversion?
por: Cahill, Catherine M., et al.
Publicado: (2014)

Opioid receptor desensitization: mechanisms and its link to tolerance
por: Allouche, Stéphane, et al.
Publicado: (2014)

Modulation of the ATP-Binding Cassette B1 Transporter by Neuro-Inflammatory Cytokines: Role in the Pathogenesis of Alzheimer's Disease
por: Alasmari, Fawaz, et al.
Publicado: (2018)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications
por: Streicher, John M., et al.
Publicado: (2017)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2023)

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
por: Dalefield, Martin L., et al.
Publicado: (2022)

Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
por: Scuderi, Caterina, et al.
Publicado: (2014)

Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
por: Morgese, Maria Grazia, et al.
Publicado: (2019)

The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
por: Abd-Elrahman, Khaled S., et al.
Publicado: (2023)

Editorial: Opioids and opioid-use disorders
por: de Guglielmo, Giordano, et al.
Publicado: (2023)

Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
por: Liao, Wang, et al.
Publicado: (2022)

Biological and therapeutic role of LSD1 in Alzheimer’s diseases
por: Li, Yu, et al.
Publicado: (2022)

Advances in the roles and mechanisms of lignans against Alzheimer’s disease
por: Han, Na, et al.
Publicado: (2022)

Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions
por: Iwaszkiewicz, Katerina S., et al.
Publicado: (2013)

Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
por: Chartoff, Elena H., et al.
Publicado: (2015)

Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation
por: Chavkin, Charles, et al.
Publicado: (2019)

Xueshuantong Improves Functions of Lymphatic Ducts and Modulates Inflammatory Responses in Alzheimer’s Disease Mice
por: Zheng, Rui, et al.
Publicado: (2021)

Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications
por: Dal Prà, Ilaria, et al.
Publicado: (2019)

Differential Patterns of Adherence to Opioid Therapy in Opioid Naïve and Opioid Existing Patients With Different Age Groups
por: Zin, Che Suraya, et al.
Publicado: (2019)

Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence
por: Kaplan, Gary B., et al.
Publicado: (2023)

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test
por: Laman-Maharg, Abigail, et al.
Publicado: (2018)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)

Targeting NMDA receptor in Alzheimer’s disease: identifying novel inhibitors using computational approaches
por: Siddiqui, Arif Jamal, et al.
Publicado: (2023)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
por: Zhang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjtjqvtj9ddee35dpank5ve240